Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
4
|
Resverlogix Corp.
|
Sep 19, 2020 02:57AM
|
Re: New York Times
|
4
|
Resverlogix Corp.
|
Mar 08, 2022 08:13PM
|
Re: Zenith Payoff of Citi?
|
4
|
Resverlogix Corp.
|
Apr 05, 2017 11:52AM
|
Re: Credit Suisse was the big seller....
|
4
|
Resverlogix Corp.
|
Dec 10, 2018 04:52PM
|
Re: Shorts don't operate in a vaacum......
|
4
|
Resverlogix Corp.
|
Jul 09, 2019 12:29PM
|
Re: The biggest unanswered question - Where's the money?
|
4
|
Resverlogix Corp.
|
Dec 07, 2019 10:51PM
|
Re: Article in Nature - An epigenetics gold rush: new controls for gene expression
|
4
|
Resverlogix Corp.
|
Feb 23, 2017 02:57AM
|
Re: New RVX Tweet
|
4
|
Resverlogix Corp.
|
Aug 01, 2020 04:22AM
|
Re: General chances of success
|
4
|
Resverlogix Corp.
|
Feb 06, 2019 01:01PM
|
Re: Webcast is up
|
4
|
Resverlogix Corp.
|
Nov 01, 2019 01:32AM
|
Re: Epizyme market cap $750 mil USd
|
4
|
Zenith Epigenetics
|
Jun 16, 2017 12:38PM
|
Re: BETonMACE top line data
|
4
|
Resverlogix Corp.
|
Jan 17, 2018 12:13AM
|
Re: Is this relevant to RVX
|
4
|
Resverlogix Corp.
|
May 16, 2020 12:21PM
|
Re: Where are the Questions ?
|
4
|
Resverlogix Corp.
|
Jun 21, 2022 07:32PM
|
Re: SP 884+ Week Low.
|
4
|
Resverlogix Corp.
|
Oct 15, 2022 01:45PM
|
Re: What if RRR MACE is significant at 90% confidence?
|
4
|
Resverlogix Corp.
|
Apr 23, 2018 04:39PM
|
Re: Top Resverlogix Shareholders
|
4
|
Resverlogix Corp.
|
Apr 02, 2019 04:38PM
|
Re: Renal trial delayed (again)
|
4
|
Resverlogix Corp.
|
Sep 28, 2017 11:13AM
|
Re: One week later....
|
4
|
Resverlogix Corp.
|
May 20, 2021 03:31PM
|
Re: Broker Meeting 23 Feb
|
4
|
Resverlogix Corp.
|
Mar 01, 2017 11:00AM
|